These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24726377)
21. A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain. Wehrhahn MC; Keighley C; Kurtovic J; Knight DR; Hong S; Hutton ML; Lyras D; Wang Q; Leong R; Borody T; Edye M; Riley TV Anaerobe; 2019 Feb; 55():117-123. PubMed ID: 30500477 [TBL] [Abstract][Full Text] [Related]
22. [Clostridium-difficile-associated infections]. Eckert C; Barbut F Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046 [TBL] [Abstract][Full Text] [Related]
23. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection. Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166 [TBL] [Abstract][Full Text] [Related]
24. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin. Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985 [TBL] [Abstract][Full Text] [Related]
25. The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. Tae CH; Jung SA; Song HJ; Kim SE; Choi HJ; Lee M; Hwang Y; Kim H; Lee K J Korean Med Sci; 2009 Jun; 24(3):520-4. PubMed ID: 19543521 [TBL] [Abstract][Full Text] [Related]
26. [Antimicrobial susceptibilities and molecular characterization of toxin-positive Clostridium difficile isolates: the first report on the presence of hypervirulent strains from Turkey]. Salman E; Levent B; Karahan ZC Mikrobiyol Bul; 2017 Jul; 51(3):236-246. PubMed ID: 28929960 [TBL] [Abstract][Full Text] [Related]
27. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994 [TBL] [Abstract][Full Text] [Related]
28. [Percutaneous endoscopic colostomy for treatment of an antibiotic-induced pseudomembranous colitis]. Prassler R Dtsch Med Wochenschr; 2008 Oct; 133(44):2268-71. PubMed ID: 18946851 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden. Rashid MU; Lozano HM; Weintraub A; Nord CE Anaerobe; 2013 Apr; 20():32-5. PubMed ID: 23454525 [TBL] [Abstract][Full Text] [Related]
30. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106. Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938 [TBL] [Abstract][Full Text] [Related]
31. A MLST Clade 2 Clostridium difficile strain with a variant TcdB induces severe inflammatory and oxidative response associated with mucosal disruption. Costa CL; López-Ureña D; de Oliveira Assis T; Ribeiro RA; Silva RO; Rupnik M; Wilcox MH; de Carvalho AF; do Carmo AO; Dias AA; de Carvalho CB; Chaves-Olarte E; Rodríguez C; Quesada-Gómez C; de Castro Brito GA Anaerobe; 2016 Aug; 40():76-84. PubMed ID: 27311833 [TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile and the disease it causes. Norén T Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore. Koh TH; Tan AL; Tan ML; Wang G; Song KP Pathology; 2007 Aug; 39(4):438-42. PubMed ID: 17676487 [TBL] [Abstract][Full Text] [Related]
34. Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. Kato H; Kato N; Watanabe K; Yamamoto T; Suzuki K; Ishigo S; Kunihiro S; Nakamura I; Killgore GE; Nakamura S J Clin Microbiol; 2001 Apr; 39(4):1391-5. PubMed ID: 11283061 [TBL] [Abstract][Full Text] [Related]
35. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Borgmann S; Kist M; Jakobiak T; Reil M; Scholz E; von Eichel-Streiber C; Gruber H; Brazier JS; Schulte B Euro Surveill; 2008 Dec; 13(49):. PubMed ID: 19081002 [TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381 [TBL] [Abstract][Full Text] [Related]
38. Isolation of the first three cases of Clostridium difficile polymerase chain reaction ribotype 027 in Singapore. Lim PL; Ling ML; Lee HY; Koh TH; Tan AL; Kuijper EJ; Goh SS; Low BS; Ang LP; Harmanus C; Lin RT; Krishnan P; James L; Lee CE Singapore Med J; 2011 May; 52(5):361-4. PubMed ID: 21633771 [TBL] [Abstract][Full Text] [Related]